2026 AGENDA
Basel, 6 - 8 October 2026
Schedule
Create your personal agenda –check the favourite icon
Oct 68:55
Conference pass
Chair's remarks
Keynotes
Nazim Unlu, Global HR&Transformation Lead, Novartis
Oct 69:00
Conference pass
How AI is changing for drug discovery at Novartis
Keynotes
Christian Diehl, Chief Data & Digital Officer Biomedical Research, Novartis AG
Oct 69:40
Conference pass
The use of agentic AI in R&D
Keynotes
Moderator: Jorge Tavares, BI & Data Analytics Director Oncology, GSK
Emma Eng, Senior Director, PS Data and AI Solutions, Novo Nordisk
Oct 610:20
Conference pass
BioTechX Connect
Keynotes
1 hour. For Partners. Optimal Efficiency
A dedicated power-hour of pre-scheduled 1:1 meetings designed to solve specific challenges
- The format: 4x15 minute meetings
- The Goal: Rapid sourcing and partnership vetting
- The Match: 100% double opt- in (AI-Powered)
Oct 611:40
Conference pass
Chair's remarks
Large Language models
Syed Ali Shirazi, Head of Smart Factory, Sanofi
Oct 611:40
Conference pass
Chair's remarks
Data Management, Storage and Architecture
Pierre Fischer, Product Line Lead Data Platforms, F. Hoffmann-La Roche Ltd
Oct 611:40
Conference pass
Chair's remarks
Data Integration + FAIR
Deepak Unni, Scientific Coordinator, SIB Swiss Institute of Bioinformatics
Oct 611:40
Conference pass
Chair's remarks
Real World Data and Evidence
Crina Samarghitean, Medical Doctor, Paediatrics, University of Tampere
Oct 611:40
Conference pass
Chair's remarks
Digital Health
Dr. Nick (Nemanja) Kovacev, Surgeon/Engineer, OrtoMD Polyclinic
Oct 611:40
Conference pass
Chair's remarks
AI in Clinical Trials
Irem Nasir, R&D Engagement Lead, Sr. Data Scientist, Bayer
Oct 611:45
Conference pass
An AI powered “neural system” that enriches operational decisions in Clinical Development
AI in Clinical Trials
Guillaume Carbonneau, Vice President, Operational Data Insights, Novo Nordisk
Oct 611:45
Conference pass
Building an AI Agent on top of small language models to automate Molecular Dynamics simulations
Large Language models
Oct 611:45
Conference pass
Donor-derived cell-free DNA monitoring for personalized immunosuppression in transplantation
Digital Health
Oct 611:45
Conference pass
From Data to Design: Building Platforms for Medicinal Chemistry
Cheminformatics
Oct 611:45
Conference pass
Increasing engagement with digital health
Digital Transformation
Thomas Boillat, Senior Digital Health Product Lead, Roche
Oct 611:45
Conference pass
Multimodal Data Assets - Optimizing Drug Development with Actionable Data Insights
Data Integration + FAIR
Marta Carrasco, Data Governance & Operations Lead, Roche
Oct 611:45
Conference pass
Quality of life as a real-world endpoint
Real World Data and Evidence
Oct 611:45
Conference pass
Research data modelling at scale
Data Management, Storage and Architecture
Johannes Meuthen, Associate Director - Product Management Data Modeling, Novartis
Oct 611:45
Conference pass
Utilising multimodal data in early drug development
AI in Drug Discovery and Development
Marc Osterland, Machine Learning Engineer, Bayer
Oct 612:05
Conference pass
Enabling AI for modern drug discovery: from multimodal data to target and further
AI in Drug Discovery and Development
Jan Majta, Director of AI Solutions, Ardigen
Oct 612:05
Conference pass
Scaling the Complexity: Data Infrastructure Challenges for Macromolecules and Monomer Libraries
Data Management, Storage and Architecture
Csaba Peltz, Director of Chemistry, Certara
Oct 612:05
Conference pass
The Foundation for Trustworthy AI: From FAIR Data Principles to Enterprise-Ready AI in Pharma
Data Integration + FAIR
Mark Hahnel, VP of Open Research, Digital Science
Oct 612:25
Conference pass
AI in Model-Informed Drug Development (MIDD)
AI in Drug Discovery and Development
Igor Goryanin, Professor, University of Edinburgh
Oct 612:25
Conference pass
Applications of biological foundation models to accelerate clinical trials
AI in Clinical Trials
Neil Pfister, Assistant Professor; Head of AI in Precision Medicine Research Group, University of Alabama at Birmingham
Oct 612:25
Conference pass
Computational approaches for target discovery
Bioinformatics + InSilico R&D
Becky Saunders, Associate Director, Computational Biologist, Tangram Therapeutics
Oct 612:25
Conference pass
Driving Organisational Change Through Digital Transformation at Novartis
Digital Transformation
Nazim Unlu, Global HR&Transformation Lead, Novartis
Oct 612:25
Conference pass
Evidence generation in early-stage drug development
Real World Data and Evidence
Moritz Saxenhofer, Senior Manager Translational Research, CSL Behring
Oct 612:25
Conference pass
Generative AI in service of data life cycle management
Data Management, Storage and Architecture
Pierre Fischer, Product Line Lead Data Platforms, F. Hoffmann-La Roche Ltd
Oct 612:25
Conference pass
Generative Chemistry
Cheminformatics
Antoine Taly, Research director, CNRS
Oct 612:25
Conference pass
Human Gut Microbiome Health redefined
Digital Health
Kinga Zielinska, Bioinformatician, Jagiellonian University
Oct 612:25
Conference pass
Tailored GenAI Solutions for Enterprise Use Cases
Large Language models
Mario Sanger, Senior AI / NLP engineer, AstraZeneca
Oct 612:25
Conference pass
The Power of an R&D Unified Data Catalog with Domain Models: Accelerating Insights and Enhancing Data Governance
Data Integration + FAIR
Stefanie Holt-Noreiks, R&D Data Operations, Bayer AG
Friederike Stoll, Data Strategy & Governance, Bayer AG
Oct 612:45
Conference pass
Agentic AI and large language models: Tapping into new drug discovery possibilities
Bioinformatics + InSilico R&D
Oct 613:05
Conference pass
Benefits of AI in signal management workflow
Real World Data and Evidence
Philip Jones, Senior Director, Disease Area Cluster Lead, CVMWH, Pfizer
Oct 613:05
Conference pass
DCAM (Data management capability assessment model) framework
Data Management, Storage and Architecture
Tobias Thonak, Partner, ETH
Oct 613:05
Conference pass
Digital Transformation in pharmaceutical Manufacturing
Digital Transformation
Frank Thielmann, Head Business Processes of the Future, Takeda
Oct 613:05
Conference pass
Enhancing discoverability with the SPHN Metadata Catalog
Data Integration + FAIR
Deepak Unni, Scientific Coordinator, SIB Swiss Institute of Bioinformatics
Oct 613:05
Conference pass
Evaluating digital health opportunities: An investor perspective.
Digital Health
Maria Escala-Garcia, Investment Associate, Vi Partners
Oct 613:05
Conference pass
From unstructured distributed real-world healthcare data to Virtual Health Twins
Large Language models
Oct 613:05
Conference pass
ML in drug discovery
AI in Drug Discovery and Development
Damian Roqueiro, Senior Scientist, Roche
Oct 613:05
Conference pass
Programmable medicine with digital twins
Bioinformatics + InSilico R&D
Jake Chen, Endowed Professor and Director, University of Alabama at Birmingham
Oct 613:05
Conference pass
There’s no AI in 'Silo': Decentralized Clinical Trials, from Patients to Nations
AI in Clinical Trials
Oct 613:05
Conference pass
UniProt, Rhea and Chebi: Biological curation with a Chemical impact
Cheminformatics
Oct 613:25
Conference pass
Roundtables
Roundtables
AI in Model-Informed Drug Development (MIDD)
Igor Goryanin, Professor, University of Edinburgh
AI-powered drug discovery for startups & mid-sized biotech. Build, buy, or partner
Generative AI adoption: drivers and barriers
Philippe Barillon, Executive Director, Novartis
How to bridge academia and industry
Gisela Andrade, senior Innovation expert, Basel innovation area
Implementing AI in Cell and Gene Therapy
Marianne Henry, Senior Scientist, Cell and Gene Therapy Catapult
Lost in the Numbers: Managing Data Overload?
Agnes Maria Kelm, Commercial Insights & Analytics Manager, Novo Nordisk
Self-Driving Laboratories in Drug Discovery
Oct 614:25
Conference pass
BioTechX Connect
Keynotes
1 hour. For Partners. Optimal Efficiency
A dedicated power-hour of pre-scheduled 1:1 meetings designed to solve specific challenges
- The format: 4x15 minute meetings
- The Goal: Rapid sourcing and partnership vetting
- The Match: 100% double opt- in (AI-Powered)
Oct 615:25
Conference pass
Chair's remarks
Bioinformatics + InSilico R&D
Jake Chen, Endowed Professor and Director, University of Alabama at Birmingham
Oct 615:25
Conference pass
Chair's remarks
AI in Drug Discovery and Development
Oct 615:25
Conference pass
Chair's remarks
Data Integration + FAIR
Deepak Unni, Scientific Coordinator, SIB Swiss Institute of Bioinformatics
Oct 615:25
Conference pass
Chair's remarks
Real World Data and Evidence
Crina Samarghitean, Medical Doctor, Paediatrics, University of Tampere
Oct 615:25
Conference pass
Chair's remarks
Digital Health
Dr. Nick (Nemanja) Kovacev, Surgeon/Engineer, OrtoMD Polyclinic
Oct 615:25
Conference pass
Chair's remarks
Data Management, Storage and Architecture
Pierre Fischer, Product Line Lead Data Platforms, F. Hoffmann-La Roche Ltd
Oct 615:30
Conference pass
Bioinformatics & AI for nucleic acid therapeutics safety
Bioinformatics + InSilico R&D
Francesca Mugianesi, Associate Director, AstraZeneca
Oct 615:30
Conference pass
Building an open scientific RWD platform
Real World Data and Evidence
Abhishek Choudhary, Principal Data Engineer, Bayer AG
Leonardo D'Ambrosi, Principal Data Scientist, Bayer Pharma AG
Oct 615:30
Conference pass
Cheminformatics for HIT discovery
Cheminformatics
Dusan Petrovic, Data Scientist, Novartis
Oct 615:30
Conference pass
Digital fundamendals of hybrid care
Digital Health
Jan-Herman Spanjersberg, Chief Information Officer, Arts en Zorg
Oct 615:30
Conference pass
End-to-end AI Implementation in Dossier Submission
AI in Clinical Trials
Daryna Smyrnova, Data & AI Lead, argenx
Oct 615:30
Conference pass
FAIRifying patient registries in hemoglobinopathy research
Data Integration + FAIR
Maria Xenophontos, Lab Scientific Officer - Bioinformatician, The Cyprus Institute of Neurology and Genetics
Oct 615:30
Conference pass
Information grounding of LLMs using knowledge graphs and documents
Large Language models
Nikola Milosevic, Technical ecosystem owner, Bayer
Oct 615:30
Conference pass
It all about change - are we AI ready
Digital Transformation
Oct 615:30
Conference pass
Modernisation of the Statistical Computational Environment
Data Management, Storage and Architecture
Philip Young, Global Head Biostatistics & Data Science, Boehringer Ingelheim
Oct 615:30
Conference pass
Utilizing an organ-chip platform to improve digital twin models
AI in Drug Discovery and Development
Christopher Belnap, Entrepreneur in Residence, University of Luxembourg
Oct 615:50
Conference pass
A Practical Path to AI-Grounded Drug Discovery with Knowledge Graphs
AI in Drug Discovery and Development
Mark Hahnel, VP of Open Research, Digital Science
Oct 616:10
Conference pass
Building a Trusted Research Environment to enable Biobank data analysis at scale and enable secondary use of internal clinical data
Bioinformatics + InSilico R&D
Oct 616:10
Conference pass
Digital Transformation through AI and data analytics
Digital Transformation
Syed Ali Shirazi, Head of Smart Factory, Sanofi
Oct 616:10
Conference pass
Exploratory rare variant analysis in neurodegeneration using AI within UK Biobank and clinical trials
AI in Clinical Trials
Oct 616:10
Conference pass
Exploring the Future of Preclinical Research: Our AI Chatbot for Data Annotation, Retrieval and Writing Assistance
Large Language models
Annika Kreuchwig, Senior Data Scientist, Bayer
Oct 616:10
Conference pass
FAIR business value framework
Data Integration + FAIR
Giovanni Nisato, Project Manager, Pistoia Alliance
Oct 616:10
Conference pass
How digital health is transforming our care system
Digital Health
Silke Kiessling, Lecturer in Chronobiology, University of Surrey
Oct 616:10
Conference pass
Partnerships between industry and public sector
AI in Drug Discovery and Development
Antonio Ruiz-Gonzalez, Project Manager, Health Innovation Network South London
Oct 616:10
Conference pass
Predictive & Generative Modelling in Drug Design Opportunities and Challenges of Augmented Intelligence
Cheminformatics
Nils Weskamp, Head of Data & Digital Science, Boehringer Ingelheim Pharma GmbH & Co. KG
Oct 616:10
Conference pass
Strategic foresight for prioritisation of AI applications in RWE
Real World Data and Evidence
Alireza Moayyeri, Senior RWE Expert, UCB
Oct 616:10
Conference pass
The Backbone of Modern Medicine: Scaling NHS Data Infrastructure for Precision Healthcare
Data Management, Storage and Architecture
Lawrence Adams, Prinicpal Data Engineering, Guy's & St. Thomas's NHS Foundation Trust
Oct 616:30
Conference pass
In Silico-Enabled Biologics: Transforming Molecular Biology Design Through Integrated Informatics
Digital Transformation
Veronica DeFelice, Director of Biologics, Sapio Sciences
Oct 616:30
Conference pass
Making innovation simple: scaling what works
Data Management, Storage and Architecture
Enrico Pandolfo, Data Strategy Execution Lead, Roche
Oct 616:50
Conference pass
Accelerating recruitment with engaged real-world data cohorts
Digital Health
Andrew Miles, Chief Business Officer, Our Future Health
Oct 616:50
Conference pass
Bridging the gap between FEMtech and FEMhealth
Real World Data and Evidence
Michael Liebman, Managing Director, IPQ Analytics, LLC
Oct 616:50
Conference pass
Digital transformation within our corporate entity
AI in Clinical Trials
Oct 616:50
Conference pass
Drug Development Data Platform and Data Integration + FAIR
Data Integration + FAIR
Ander Sainz Loyola, Lead Data Engineer, Research Data Platform, AstraZeneca
Oct 616:50
Conference pass
GenAI and Knowledge Graphs and how these technologies can accelerate the drug development pipeline
Large Language models
Jobst Loeffler, Product Owner, Bayer
Oct 616:50
Conference pass
How AstraZeneca are working on ontologies
Data Management, Storage and Architecture
Oct 616:50
Conference pass
LLMs and knowledge graphs
Digital Transformation
Tankred Ott, Product Lead, FounData, Novo Nordisk
Oct 616:50
Conference pass
Predictive Toxicology: Rational Digital Toxicology in the Cloud with a New AI-Accelerated Physics-Based Workflow
AI in Drug Discovery and Development
Oct 617:25
Conference pass
Autonomous R&D: Transforming Data and Regulatory Complexity into a Strategic Decision Advantage
Digital Transformation
Moderator: Monika Magon, Product Owner/Business Analyst, Roche
Rolf Jautelat, VP R&D Data Science & AI, Bayer
Oct 617:25
Conference pass
Beyond the App: Data, People, and the Real Foundations of Digital Health
Digital Health
Marcelo Oliveira, Senior Director Commercialization Digital Health, Roche
Mieke Van Hemelrijck, Professor in Cancer Epidemiology, King's College London/Guy's Cancer Centre
Oct 617:25
Conference pass
Data Management & Readiness for AI
Data Management, Storage and Architecture
Moderator: Syed Ali Shirazi, Head of Smart Factory, Sanofi
Pierre Fischer, Product Line Lead Data Platforms, F. Hoffmann-La Roche Ltd
Pascal Hofer, Head Legal Digital & IT, F. Hoffmann-La Roche AG
Alireza Moayyeri, Senior RWE Expert, UCB
Oct 617:25
Conference pass
Data structures and FAIR processes
Data Integration + FAIR
Moderator: Monika Mehra, Associate Director Reference Data Management, AstraZeneca
Oct 617:25
Conference pass
From Data to Diagnosis: The Power of Multi-Omics in Clinical Research
Bioinformatics + InSilico R&D
Moderator: Hoda Sharifian, Senior Scientist - Bioinformatics, Molecular Partners
Jake Chen, Endowed Professor and Director, University of Alabama at Birmingham
Oct 617:25
Conference pass
Improving patient care
Real World Data and Evidence
Moderator: Theodora Weisz, Patient Advocacy and Public Affairs Expert, former Novartis
Guillaume Wendt, Evidence Generation Director, Novartis Germany
Oct 617:25
Conference pass
Navigating AI Adoption in Clinical Trials
AI in Clinical Trials
Moderator: Matilda Males, Strategy Director, Clinical Development, Novartis
Margarita Mersiyanova, Senior Industry Consultant, Global Health and Life Sciences Customer Advisory, SAS Software Limited
Thomas Boillat, Senior Digital Health Product Lead, Roche
Create your personal agenda –check the favourite icon
Oct 78:15
Conference pass
BioTechX Connect
Keynotes
1 hour. For Senior Decision Makers. Optimal Efficiency
A dedicated power-hour of pre-scheduled 1:1 meetings designed to solve specific challenges
- The format: 4x15 minute meetings
- The Goal: Rapid sourcing and partnership vetting
- The Match: 100% double opt- in (AI-Powered)
Oct 79:05
Conference pass
Chair's remarks
Keynotes
Abhishek Choudhary, Principal Data Engineer, Bayer AG
Oct 79:10
Conference pass
From Hearing to Brain Health: Biomarkers as a Breakthrough in Early Neuro-Diagnosis and inflammatory diseases
Keynotes
Jerome Geoffroy, CFO & Chief Digital Officer, Cilcare
Oct 710:30
Conference pass
BioTechX Connect
Keynotes
1 hour. For Partners. Optimal Efficiency
A dedicated power-hour of pre-scheduled 1:1 meetings designed to solve specific challenges
- The format: 4x15 minute meetings
- The Goal: Rapid sourcing and partnership vetting
- The Match: 100% double opt- in (AI-Powered)
Oct 711:40
Conference pass
Chair's remarks
AI in Drug Discovery and Development
Oct 711:40
Conference pass
Oct 711:40
Conference pass
Chair's remarks
Large Language models
Tankred Ott, Product Lead, FounData, Novo Nordisk
Oct 711:40
Conference pass
Chair's remarks
AI for imaging
Andrew Miles, Chief Business Officer, Our Future Health
Oct 711:40
Conference pass
Chair's remarks
Data Integration + FAIR
Mario Pepe, NCS Senior Expert -Systems Toxicology and Computational sciences Lead, Boehringer Ingelheim
Oct 711:40
Conference pass
Chair's remarks
Digital Transformation
Jan-Herman Spanjersberg, Chief Information Officer, Arts en Zorg
Oct 711:40
Conference pass
Oct 711:40
Conference pass
Chair's remarks
Clinical Technology & Innovation
Crina Samarghitean, Medical Doctor, Paediatrics, University of Tampere
Oct 711:45
Conference pass
Agentic AI for trial design
AI in Clinical Trials
Rasmus Sten Andersen, Associate Director, Product and AI, Novo Nordisk
Oct 711:45
Conference pass
Bayer's Digital Transformation in R&D: what are the key catalysts
Digital Transformation
Claudia Vogt, Chief of Staff R&D Data Science & AI, Bayer AG
Oct 711:45
Conference pass
Clinical validation of AI tools
Clinical Technology & Innovation
Crina Samarghitean, Medical Doctor, Paediatrics, University of Tampere
Oct 711:45
Conference pass
Enable compliant preclinical discovery data sharing between organizations
Data Integration + FAIR
Michael Lange, IT Project Leader, F. Hoffmann-La Roche Ltd
Oct 711:45
Conference pass
LLMs inside company
Large Language models
Robert Di Giovanni, Senior Global Patient Safety Lead, Novartis Pharma AG
Oct 711:45
Conference pass
NHS secured data environments for RWE generation
Real World Data and Evidence
Adrian Jonas, Chief Analyst for the North West Region, NHS
Oct 711:45
Conference pass
Phenomic immune-health profiling through self-supervised representation learning
AI for imaging
Tim Heinemann, Senior Computational Biologist, CSEM
Oct 711:45
Conference pass
Prevention instead of treatment, medicine 3.0
Bioinformatics + InSilico R&D
Boryana Petrova, Director Research Metabolomics Unit, University of Vienna
Oct 711:45
Conference pass
The rapidly changing landscape for precision health at a tertiary children’s hospital
Digital Health
Oct 711:45
Conference pass
Utilising multimodal data in early drug development
AI in Drug Discovery and Development
Oct 712:05
Conference pass
Designed In, Not Bolted On: Why Change Management Is the Missing Infrastructure in Clinical AI Deployments
Clinical Technology & Innovation
As of late 2024, only 11% of pharmaceutical and biotech companies had fully implemented AI in clinical trial operations — despite years of investment and a technology landscape that has never been more capable. A 2025 McKinsey analysis puts the broader problem in stark terms: more than 80% of organizations report no measurable enterprise-level impact from generative AI. The technology isn't the bottleneck. The organizations receiving it are.
Across clinical operations, a predictable pattern is emerging: a tool clears validation, clears IT, clears legal — and then stalls at the team level. Adoption plateaus. Workarounds persist. The ROI case erodes. Emerging evidence now challenges the assumption that resistance is the culprit. The real barrier is structural: change management is routinely treated as a communication plan appended after build — a series of emails, a training session, a launch announcement. In clinical operations, where process discipline is a compliance requirement, that gap has consequences well beyond a missed adoption metric.
This session makes the case that organizational readiness is not a soft skill — it's a deployment requirement. Drawing on patterns across multiple AI and automation programs in clinical development, this talk presents three design principles that must be embedded at program inception, not activated at go-live:
- Stakeholder impact precedes requirements. Who absorbs the process change, and what does it cost them? That answer should shape the tool design, not follow it.
- Adoption metrics are success criteria, not afterthoughts. If you can't measure behavior change, you can't claim the benefit.
- Capability building is a workstream, not an event. Sustained adoption requires ongoing investment in people infrastructure — not a one-time training push.
Attendees will leave with a diagnostic lens for identifying where their current AI deployments are structurally at risk — and a practical framework for designing organizational readiness in from day one.
Sara Huehls, Associate Director CDD Hub AI & Automation Lead, Eli Lilly and Company
Oct 712:25
Conference pass
AI for bioinformatics
Bioinformatics + InSilico R&D
Sofia Lotfi, Senior Data Scientist, Drug Discovery, Servier
Oct 712:25
Conference pass
Beyond the Silos: Navigating the AI regulatory complexity
Digital Transformation
Saibal Mukherjee, Global Data Digital & Technology Legal, Takeda
Oct 712:25
Conference pass
Building an agentic AI platform to improve efficiency across the value chain
Large Language models
Christophe Chabbert, Group Lead, Data & AI, Octapharma Biopharmaceuticals GmbH
Oct 712:25
Conference pass
Continued real world evidence driven by AI
Real World Data and Evidence
Pablo Azcue, Franchise Head GI Oncology, AstraZeneca
Oct 712:25
Conference pass
From Prediction to Validation: An Industry-Standard Approach to TCR-Mimic Antibody Development
AI in Drug Discovery and Development
Oliver Selinger, Head of Digital and Data, BioCopy GmbH
Oct 712:25
Conference pass
Guy's Cancer Real World Evidence Programme - an opportunity for collaborative digital health.
Digital Health
Mieke Van Hemelrijck, Professor in Cancer Epidemiology, King's College London/Guy's Cancer Centre
Oct 712:25
Conference pass
Image analysis in cryoEM to rationalise drug discovery
AI for imaging
Alexey Rak, Head of Biostructure and Biophysics, Sanofi
Oct 712:25
Conference pass
Lighthouse Assistant: Exploiting FAIR Knowledge Graphs and Agentic Workflows for Clinical Study metadata management
Data Integration + FAIR
Javier Fernandez, Principal Data Scientist, Roche
Adam Forys, Principal Data Scientist, Roche
Oct 712:25
Conference pass
Preventing Avoidable Clinical Protocol Amendments using AI
AI in Clinical Trials
Oct 713:05
Conference pass
AI for diagnostic imagining in neurodegenerative disease
AI for imaging
Ruiqing Ni, Principal investigator, Inselspital & University of Bern
Oct 713:05
Conference pass
Biomedical Informatics Platform, (LOOP BMIP)
Real World Data and Evidence
Olga Mineeva, Product Manager, ETHZ
Aleksandar Bobic, Deputy Group Leader, ETH Zurich
Oct 713:05
Conference pass
Engineering Certainty and Clinical Safety: From Probabilistic to Deterministic AI
Large Language models
Dr. Nick (Nemanja) Kovacev, Surgeon/Engineer, OrtoMD Polyclinic
Oct 713:05
Conference pass
From Noise to Guidance: Rethinking Alerts in EMR Systems
Clinical Technology & Innovation
Clinical decision support (CDS) alerts in EMR systems aim to support clinical decisions, yet many are viewed as noise: frequent, disruptive, and often necessary to override. In part, this is because existing CDS alert design recommendations have been shaped predominantly by principles of usability and human factors engineering, which tend to emphasise the limitations of human cognition rather than the complexities of human decision-making. This session presents a different approach: designing alerts not as expedient solutions, but as interventions to guide clinical decisions in ways better aligned with how humans actually make decisions.
Drawing on doctoral research in digital health, the session introduces a multidimensional model for designing CDS alerts with human decision-making considerations. The model defines and organises nine building blocks of CDS alerts and demonstrates how nine behavioural effects from the MINDSPACE framework for behaviour change can inform their design. Developed through design-science research and informed by several conceptual and empirical studies, including interviews with CDS alert designers and users, as well as digital health practitioners and academics, it offers a structured and behaviourally informed approach to rethinking alerts as more meaningful interventions to guide clinical decisions.
Oct 713:05
Conference pass
From Shopfloor to Agentic Enterprise: How Roche Is Operationalizing AI in Manufacturing
Data Integration + FAIR
Lukasz Pakula, Head of Data Integration, MCP and Streaming, Roche
Oct 713:05
Conference pass
How non for profit harnesses AI in clinical trials
AI in Clinical Trials
Oct 713:05
Conference pass
Human genomics in the age of AI
Bioinformatics + InSilico R&D
Ali Saadat, Scientific assistant, EPFL
Oct 713:05
Conference pass
Medical Value Algorithms for Diagnostics and Improvement of Care Along the Patient Journey
Digital Health
Oct 713:05
Conference pass
Pierre Fabre transformation journey
AI in Drug Discovery and Development
Audrey Kauffmann, Head Data Science and Biometrics, Pierre Fabre Laboratories
Oct 713:05
Conference pass
The adoption gap: why digital transformations fail on Shopfloor (and how to fix it)
Digital Transformation
Reka Babos, Business Analyst, Novo Nordisk A/S
Oct 714:25
Conference pass
BioTechX Connect
Keynotes
1 hour. For Partners. Optimal Efficiency
A dedicated power-hour of pre-scheduled 1:1 meetings designed to solve specific challenges
- The format: 4x15 minute meetings
- The Goal: Rapid sourcing and partnership vetting
- The Match: 100% double opt- in (AI-Powered)
Oct 715:25
Conference pass
Chair's remarks
AI for imaging
Andrew Miles, Chief Business Officer, Our Future Health
Oct 715:25
Conference pass
Chair's remarks
AI in Drug Discovery and Development
Xeniya Kofler, Regulatory Compliance Scientist, CSL Behring
Oct 715:25
Conference pass
Oct 715:25
Conference pass
Chair's remarks
Large Language models
Olga Mineeva, Product Manager, ETHZ
Oct 715:25
Conference pass
Chair's remarks
Digital Health
Mike Makrigiorgos, Professor For Department Of Radiation Oncology, Dana Farber and Harvard Medical School
Oct 715:25
Conference pass
Chair's remarks
Digital Transformation
Jason Beckwith, Professor, University of Dundee
Oct 715:25
Conference pass
Chair's remarks
Data Integration + FAIR
Mario Pepe, NCS Senior Expert -Systems Toxicology and Computational sciences Lead, Boehringer Ingelheim
Oct 715:25
Conference pass
Chair's remarks
Real World Data and Evidence
Deni Subasic, Network Innovation Director, Roche
Oct 715:30
Conference pass
Accelerating discoveries in diagnostic biomarkers using AI solutions
AI in Drug Discovery and Development
Oct 715:30
Conference pass
AI Driven Endpoints: Redifining Clinical Trials for the next decade
AI for imaging
Oct 715:30
Conference pass
Change management in the age of AI
Digital Transformation
Sara Mullis, OCM Specialist, Roche
Oct 715:30
Conference pass
Driving decision making from target discovery to the clinic
Bioinformatics + InSilico R&D
Nikolina Nakic, VP Target Discovery, Artificial Intelligence & Digital Innovation, Novo Nordisk
Oct 715:30
Conference pass
ELNs and Academia - a difficult story
Data Integration + FAIR
Oct 715:30
Conference pass
Novel technologies for detecting mutation and methylation-based cancer biomarkers
Digital Health
Mike Makrigiorgos, Professor For Department Of Radiation Oncology, Dana Farber and Harvard Medical School
Oct 715:30
Conference pass
Rhythms in the gut – A new target to prevent and treat diseases?
Real World Data and Evidence
Silke Kiessling, Lecturer in Chronobiology, University of Surrey
Oct 715:30
Conference pass
Target discovery using LLM
Large Language models
Seda Japp, Senior Product Lead, Bayer Pharmaceuticals
Oct 715:50
Conference pass
Lessons in building a scientist-first AI protein engineering platform
AI in Drug Discovery and Development
Jonathan Ziegler, ML Researcher, Cradle
Oct 716:10
Conference pass
Architecting the AI Lifecycle: Data Infrastructure, Model Metadata, and Synthetic Data Management
Data Integration + FAIR
Felix Peyre, Data Manager, Servier International
Oct 716:10
Conference pass
Federated Learning Interoperability Platform: Unlocking Real-World Medical Imaging for AI
AI for imaging
Alex Bagur, Senior AI Engineer, London AI Centre
Oct 716:10
Conference pass
Large Language Models in Pharma Manufacturing: Optimizing End-to-End Processes
Large Language models
Stefania Russo, Principal Data Scientist, Takeda Pharmaceuticals
Oct 716:10
Conference pass
Real World Evidence as drug development catalyzer
Real World Data and Evidence
Guillaume Wendt, Evidence Generation Director, Novartis Germany
Oct 716:10
Conference pass
Redesigning the Falls Pathway from the Inside Out: AI, Home Care, and NHS in a Single Integrated Pathway
Digital Health
Tomas Heger, Data Program Manager, Cera Care
Oct 716:10
Conference pass
The Digital Transformation Deadlock: Why Your "Integrated" (PPM) Platform is Killing Your Strategy
Digital Transformation
The promise of an "all-in-one" PPM platform is often a digital trap. My experience with enterprise-scale rollouts has shown that monolithic tools frequently create a "transformation deadlock," stifling the very decision-making they aim to support. This session introduces a Modular PPM architecture—a framework that separates your System of Record from your essential Logic and Narrative layers. Learn how to architect a technology stack that captures standardized data without sacrificing the "ground-truth" human intelligence required for high-accuracy forecasting and decisive strategic action.
Yanita Marinova, Assoc. Dir. DDIT US&I Operational Excellence & Planning, Novartis
Oct 716:30
Conference pass
Innovating towards clinical outcomes in the AI and digital health world
Digital Health
Chirag Lodhia, Deputy Director- Clinical Informatics, Monash Health
Oct 716:30
Conference pass
Why digital transformation adoption fails
Digital Transformation
Amruta Iyer, Change and Communications Strategist, Roche
Oct 716:50
Conference pass
A novel technique for sensitive detection of disease-specific T cells
Clinical Technology & Innovation
Oct 716:50
Conference pass
AI in Pathology: from pixels to precision
AI for imaging
Yasmine Makhlouf, AI and Computational Science Lead, Queen's University Belfast
Oct 716:50
Conference pass
Analysis of Clinical Pharmacokinetic Data
AI in Clinical Trials
Sam Richardson, Associate Director, ML & AI, AstraZeneca
Oct 716:50
Conference pass
Digital Transformation in Biomedical Research: Challenges and Opportunities
Digital Transformation
Jason Beckwith, Professor, University of Dundee
Oct 716:50
Conference pass
End to end evidence generation ecosystems in neuroimmunology powered by federated learning
Real World Data and Evidence
Deni Subasic, Network Innovation Director, Roche
Oct 716:50
Conference pass
Physics-Informed Large Language Models for Biologics: Applying Nuclear Engineering Rigor to AI Safety and Reliability
Large Language models
Oct 716:50
Conference pass
The Evolution of Data how agentic AI improved my life
Data Integration + FAIR
Amrik Mahal, Head of IT - Research, AstraZeneca
Oct 717:25
Conference pass
AI in clinical trials is it all a bit shit?
AI in Clinical Trials
Daryna Smyrnova, Data & AI Lead, argenx
Rasmus Sten Andersen, Associate Director, Product and AI, Novo Nordisk
Oct 717:25
Conference pass
Bridging AI and Open Source: Advancing Data Science for Clinical Quality by IMPALA consortium
Digital Transformation
Moderator: Ioannis Spyroglou, Associate Director, Data Science, MRL QA Analytics & Insights, MSD
Pekka Tiikkainen, Principal clinical data scientist, Bayer AG
Oct 717:25
Conference pass
Data Integration: Generating Insights with FAIR Data Principles
Data Integration + FAIR
Moderator: Yuliya Bohdan, Global AI Product Owner, Roche
Simon Riniker, Associate Director, Novartis
Mario Pepe, NCS Senior Expert -Systems Toxicology and Computational sciences Lead, Boehringer Ingelheim
Oct 717:25
Conference pass
Importance of real-world evidence for rare diseases
Real World Data and Evidence
Oct 717:25
Conference pass
Research Hospitals’ Role in Digital Health Technology Transfer: New Frontiers
Digital Health
Moderator: Ermes Mestroni, TTO head, Centro di Riferimento Oncologico IRCCS
Crina Samarghitean, Medical Doctor, Paediatrics, University of Tampere
Oct 717:25
Conference pass
The Future of Bioinformatics: Challenges, Opportunities, and Innovation
Bioinformatics + InSilico R&D
Moderator: Hakima Ibaroudene, Manager R&D, Southwest Research Institute
Kinga Zielinska, Bioinformatician, Jagiellonian University
Nikolina Nakic, VP Target Discovery, Artificial Intelligence & Digital Innovation, Novo Nordisk
Oct 717:25
Conference pass
Who Audits the Algorithm? AI Risk & Assurance in Clinical Environments
Clinical Technology & Innovation
Moderator: Francesco Orsi, Audit and Risk Data Science Manager, Roche
Oct 717:25
Conference pass
Your LLM is Monolingual – Your BioTech Company Isn’t. Now What?
Large Language models
Moderator: Ana Kotarcic, Researcher, NLP and Deep Learning, University of Zurich
Create your personal agenda –check the favourite icon
Oct 88:55
Conference pass
Introductory remarks
Keynotes
Anna Abiola, Conference Director, Terrapinn Holdings Ltd
Oct 89:05
Conference pass
The evolution of Medical Affairs: the drivers of future change, innovation and technology use.
Keynotes
Michelle Bridenbaker, Head of Medical Excellence & Communications, Recordati
Oct 89:25
Conference pass
Investment trends in AI
Keynotes
Moderator: Rana Lonnen, General Partner, Science Capital Ventures
Ailbhe Earley, Vice-President Life SciencesVice-President Life Sciences, IDA Ireland
Oct 89:55
Conference pass
BioTechX Connect
Keynotes
1 hour. For Senior Decision Makers. Optimal Efficiency
A dedicated power-hour of pre-scheduled 1:1 meetings designed to solve specific challenges
- The format: 4x15 minute meetings
- The Goal: Rapid sourcing and partnership vetting
- The Match: 100% double opt- in (AI-Powered)
Oct 811:05
Conference pass
Chair's remarks
AI in Drug Discovery and Development
Giovanni Rizzo, Partner, Indaco venture partners
Oct 811:05
Conference pass
Oct 811:05
Conference pass
Chair's remarks
Digital Health
Antonio Ruiz-Gonzalez, Project Manager, Health Innovation Network South London
Oct 811:05
Conference pass
Chair's remarks
Knowledge Graphs, Ontologies & Semantic Technologies
Becky Upton, President, Pistoia Alliance
Oct 811:10
Conference pass
AI influenced nano technology in drug discovery and development
AI in Drug Discovery and Development
Beauty Pandey, Associate Dean & Associate Professor, Woxsen University
Oct 811:10
Conference pass
Application of Artificial Intelligence and Machine Learning Techniques to Enhance Early Detection and Diagnosis of Niemann-Pick Class C1 Disease and Associated Liver Dysfunction
Bioinformatics + InSilico R&D
Oct 811:10
Conference pass
Digital Transformation and AI how to apply it effectively
Digital Transformation
Jorge Tavares, BI & Data Analytics Director Oncology, GSK
Oct 811:10
Conference pass
Discovery and engineering of next-gen immunotherapies with EMLy Co-pilot
Large Language models
Jacob Hurst, Chief Technology Officer, Etcembly
Oct 811:10
Conference pass
Quantum and AI to discover new medicines
Quantum Pharma
Romain Delassus, CIO/CPO, Qubit Pharmaceuticals
Oct 811:10
Conference pass
RWD in the NHS: A UK Perspective
Real World Data and Evidence
Emily Jin, Senior RWD Scientist, Guys and St Thomas NHS Trust
Oct 811:10
Conference pass
Swiss personalised health network
Data Integration + FAIR
Sabine Österle, Lead Sematic Interoperability Strategy and FAIR Data Team, SIB Swiss Institute of Bioinformatics
Oct 811:10
Conference pass
When Regulators Come Knocking: Building Agentic AI That Can Answer
Startup Pitches
Alistair Dootson, Head Life Sciences, EQTY Life Sciences
Tina Morrison, Head of Life Sciences, EQTY Lab
Oct 811:20
Conference pass
Challenges and Solutions for Raw Data Management in Pharmaceutical Companies
Startup Pitches
Lukas Wörz, Head of Sales, Kubidat GmbH
Oct 811:30
Conference pass
AI, you, and the future of work
Digital Transformation
Oct 811:30
Conference pass
LLMs at the University of Zurich
Large Language models
Ana Kotarcic, Researcher, NLP and Deep Learning, University of Zurich
Oct 811:30
Conference pass
Precision Cancer Vaccination: AI-Powered Prediction of Tumor Neoantigens for Individualized Cancer Vaccines
AI in Drug Discovery and Development
Oct 811:50
Conference pass
AI usage in the small molecule DMTA cycle
AI in Drug Discovery and Development
Nicolas Bernsmeier, Principal Digital Product Owner, Bayer AG
Oct 811:50
Conference pass
Beyond Clinical Trials: AI, Real‑World Evidence, and the Future of Pain Care
Real World Data and Evidence
Oct 811:50
Conference pass
How we are changing manual workflows in Novo Nordisk using agentic AI
Large Language models
Peter Vester, Lead Data Scientist, Novo Nordisk
Oct 811:50
Conference pass
Scaling Language AI for Multi-modal RWD in the NHS
Quantum Pharma
Joe Zhang, Chief Technology Officer, London AI Centre
Oct 811:50
Conference pass
Use cases transforming pharma with applied behavioural science
Digital Transformation
Jochen Baumeister, Head of Behavioral Science & Data Science, Sandoz
Oct 812:10
Conference pass
Clinical-Grade Digital Mindset – Agility & Resilience for Human+AI teams in pharma
Digital Transformation
Oct 812:10
Conference pass
From Clinical Evidence to Societal Impact: How Real-World Data Accelerates Access to Innovation
Real World Data and Evidence
Mart Vain, Head of Access & Value, Roche
Oct 812:10
Conference pass
The (R)evolution of Nanocyclix: A Data-Driven AI/ML Platform for Novel Kinase Inhibitors
AI in Drug Discovery and Development
Oct 812:30
Conference pass
Agentic AI use-cases clinical quality
Large Language models
Ioannis Spyroglou, Associate Director, Data Science, MRL QA Analytics & Insights, MSD
Oct 812:30
Conference pass
Agentic workflows and development insights
AI in Drug Discovery and Development
Nicklas Walldorf Gaardsted, Director, Head of Data & AI Modeling, Novo Nordisk
Oct 812:30
Conference pass
Pierre Fabre medical care digital transformation journey
Digital Transformation
Minh Tran-Dang, IS Director R&D Medical Care, Pierre Fabre
Oct 813:20
Conference pass
Women in Leadership Keynote Panel
Keynotes
Moderator: Irem Nasir, R&D Engagement Lead, Sr. Data Scientist, Bayer
Becky Upton, President, Pistoia Alliance
Cosima Gretton, Chief Product Officer, Our Future Health
Layla Hosseini-Gerami, Co-Founder, Chief Data Science Officer, Ignota Labs
last published: 07/May/26 12:45 GMT
Get involved at BioTechX Europe
TO SPONSOR
Jack Bebb
jack.bebb@terrapinn.com
Jordan Lavender
jordan.lavender@terrapinn.com
Jack Moseley
jack.moseley@terrapinn.com
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events